A Longitudinal Population-based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Women

Wennberg, Anna Lena; Molander, Ulla; Fall, Magnus; Edlund, Christer; Peeker, Ralph; Milsom, Ian

doi:10.1016/j.eururo.2009.01.007

Cited by 146 publications

(115 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[29][30][31][32]80 Hakkinen et al reported in their 10-year prospective study of men that the incidence rate of nocturia was greater during the latter 5 years (75/1000 men/year vs 126/1000 men/year), and that the incidence of severe nocturia strongly increased after the age of 75 years. 30 These results further confirm the strong association between aging and nocturia.…”

Section: Agingmentioning

confidence: 99%

Correlates for nocturia: A review of epidemiological studies

Yoshimura

2012

Int J of Urology

View full text Add to dashboard Cite

Abbreviations & AcronymsAbstract: Traditionally, nocturia was considered to be one of the symptoms of prostatism. However, this symptom has unusual characteristics compared with other lower urinary tract symptoms; for example, there is only a mild benefit for nocturia from treatment for benign prostatic hyperplasia. In the past decade, nocturia has been investigated as a separate symptom in epidemiological studies. These types of studies have shown various correlates for nocturia other than benign prostatic hyperplasia, as well as the prevalence of this symptom. These correlates include age, race/ethnicity, medical problems (such as hypertension, diabetes and stroke) psychological aspects, tasting habits, quality of life and even mortality. The cause-and-effect associations are not always obvious between nocturia and its correlates. In the present article, the author attempts to comprehensively review the correlates for nocturia shown by epidemiological studies.

show abstract

Section: Agingmentioning

confidence: 99%

Correlates for nocturia: A review of epidemiological studies

Yoshimura

2012

Int J of Urology

View full text Add to dashboard Cite

show abstract

“…Moreover, the few longitudinal studies have had relatively limited follow-ups (2-5 years) or no interval evaluation of the UI evolution during the study period. 25 Longitudinal studies are essential for the elucidation of the natural history of UI by clarifying the temporal relations and directions of the risk factors suggested by cross-sectional studies. 26 Longterm cohort studies also provide better evidence of causality.…”

Section: Introductionmentioning

confidence: 99%

Incidence and remission of urinary incontinence at midlife: a cohort study

Legendre

Ringa

Panjo

et al. 2014

BJOG

View full text Add to dashboard Cite

Objective Urinary incontinence (UI) is often considered to be an age-related disease that develops gradually as women grow older. Much remains to be learnt about factors that promote its incidence or its remission. Our objective was to assess its incidence and risk factors.Design Longitudinal cohort study.Setting French GAZEL cohort.Population A cohort of 4127 middle-aged women (aged 47-52 years at baseline) over an 18-year period (1990-2008).Methods UI was defined as 'difficulty retaining urine'. The question was asked at baseline and repeated every 3 years over an 18-year period. Two groups (UI incidence and remission) were analysed according to status at baseline (continent or incontinent). A multivariable analysis (Cox model) was used to estimate the risk factors for UI incidence and remission.Main outcome measures Annual incidence and remission rates and risk factors for UI incidence and remission.Results The annual incidence and remission rates for UI were 3.3% and 6.2%, respectively. High educational level (hazard ratio[HR] = 1.28; 95% confidence interval [95% CI] = 1.05-1.55), parity, i.e. at least one baby versus no baby (HR = 1.64; 95% CI = 1.19-2.27), menopause (HR = 5.44; 95% CI = 4.47-6.63), weight gain, i.e. for each kilogram change in weight (HR = 1.00; 95% CI = 1.00-1.02), onset of depressive symptoms (HR = 1.31; 95% CI = 1.09-1.57) and impairment in health-related quality of life incidence (social isolation dimension [HR = 1.29; 95% CI = 1.04-1.60] and energy dimension [HR = 1.41; 95% CI = 1.17-1.70]) were associated with an increased probability of UI. The factors associated with persistent UI were age (HR = 0.58; 95% CI = 0.55-0.61), weight gain (HR = 0.99; 95% CI = 0.98-0.99) and transition to menopausal status (HR = 1.54; 95% CI = 1.19-1.99).Conclusions Our study suggests that, in our population of middleaged women, age, menopause, weight gain, onset of depression and impaired health-related quality of life may promote UI.

show abstract

“…[1][2][3][4][5] It is well-recognized that OAB symptoms are common in other conditions, such as prostatic obstruction in men 12 and Grade 3 and 4 prolapse in women. 15 According to the ICS, patients with persistent OAB symptoms unaccompanied by hematuria or pyuria should be diagnosed with OAB, provided there is no "infection or other proven etiology."…”

Section: Discussionmentioning

confidence: 99%

“…[1][2][3][4][5] The International Continence Society (ICS) defines OAB as "urgency, with or without urge incontinence, usually with frequency and nocturia" and now recognizes that OAB is a "symptom syndrome suggestive of lower urinary tract dysfunction." 6 They recommend that the diagnosis of OAB should be restricted to those in whom urinary tract infection (UTI) and other pathology has been excluded.…”

Section: Introductionmentioning

confidence: 99%

Urogynecological conditions associated with overactive bladder symptoms in women

Forde

Davila

Marks³

et al. 2017

CUAJ

View full text Add to dashboard Cite

Cite as: Can Urol Assoc J 2017;11(3-4):E83-7. http://dx.doi.org/10.5489/cuaj.3962 Published online March 16, 2017 Abstract Introduction: Overactive bladder symptoms (OAB) affect 9-43% of women and are associated with underlying disorders, including pelvic organ prolapse (POP) and stress urinary incontinence (SUI). The aim of this study is to identify urogynecological conditions associated with OAB symptoms. Methods: This prospective, institutional review board-approved study included women referred to a tertiary centre with lower urinary tract symptoms (LUTS). All women completed the selfadministered OAB questionnaire (OABSS). Those with an OABSS ≥8, the cutoff, were considered to have OAB symptoms. Patients underwent a history and physical examination (including BadenWalker prolapse grading and stress test), 24-hour voiding diary, pad test (for urinary incontinence), urinalysis, and uroflow with post-void residual volume. Patients were classified clinically into the following: idiopathic OAB, SUI, POP, bladder outlet obstruction (BOO) neurogenic bladder (NGB), recurrent urinary tract infection (UTI), and miscellaneous. Results: In total, 148 women met the inclusion criteria with a mean age of 67 years. Only 27% had no comorbid conditions and were considered idiopathic OAB. Associated urogynecological conditions included SUI in 37%, POP in 26%, miscellaneous conditions in 18%, recurrent UTI in 11%, NGB in 9%, and BOO in 8%. Some patients met criteria for more than one category, thus the total is greater than 100%. Conclusions: In a tertiary care setting, a significant proportion of women with OAB symptoms have underlying conditions that may cause or contribute to their symptoms. Appropriate evaluation is desirable to enhance our understanding of the relationship of these conditions to the diagnosis, treatment, outcomes, and pathophysiology of OAB.

show abstract

A Longitudinal Population-based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Women

Cited by 146 publications

References 21 publications

Correlates for nocturia: A review of epidemiological studies

Correlates for nocturia: A review of epidemiological studies

Incidence and remission of urinary incontinence at midlife: a cohort study

Urogynecological conditions associated with overactive bladder symptoms in women

Contact Info

Product

Resources

About